White House scrambles to steady HHS leadership ahead of midterms

With leadership turmoil at HHS and the exit of FDA head Marty Makary, the White House is moving to nominate a new FDA commissioner and overhaul senior staff, aiming to reset relations with the agency, shift away from vaccine-focused MAHA priorities, and stabilize operations ahead of the November midterms while balancing GOP lawmakers and pharmaceutical industry pressures.